Saturday, July 11, 2026

pharma · Tuberculosis

Centers for Disease

Centers for Disease trial registry — 2 ClinicalTrials.gov studies with program phase, status, and indication context.

CN HQ
NMPA registrant Type
Company details
Status
Public
HQ
CN
Programs
1
Drugs
2
Patents
0
Intelligence · Clinical Trials

Centers for Disease clinical trials

Registry index of 2 ClinicalTrials.gov studies linked to Centers for Disease programs — each row shows trial ID, program name, phase, status, and indication.

Centers for Disease trial registry — 2 ClinicalTrials.gov studies with program phase, status, and indication context.

Recent trial activity

1 updates

Latest clinical program signals indexed for Centers for Disease.

  1. rifapentine — Phase 3

    Clinical update

Trial registry

2 studies